Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.000
+0.044 (4.62%)
At close: Nov 20, 2024, 4:00 PM
1.030
+0.030 (3.00%)
After-hours: Nov 20, 2024, 7:44 PM EST

Lucid Diagnostics Revenue

Lucid Diagnostics had revenue of $1.17M in the quarter ending September 30, 2024, with 49.68% growth. This brings the company's revenue in the last twelve months to $4.19M, up 179.27% year-over-year. In the year 2023, Lucid Diagnostics had annual revenue of $2.43M with 544.03% growth.

Revenue (ttm)
$4.19M
Revenue Growth
+179.27%
P/S Ratio
11.10
Revenue / Employee
$59,843
Employees
70
Market Cap
53.99M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.43M2.05M544.03%
Dec 31, 2022377.00K-123.00K-24.60%
Dec 31, 2021500.00K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Precision BioSciences 75.10M
Exagen 55.75M
Cytosorbents 37.74M
BGM Group 29.87M
Aadi Bioscience 25.07M
Kronos Bio 9.87M
Shattuck Labs 6.44M
Affimed 6.29M
Revenue Rankings